Mrs. Sumayah Al-Mahmood | Pharmaceutical | Best Researcher Award

Lecturer at Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Department of Basic Sciences, College of Dentistry, Al-Iraqia University, Iraq.

Dr. Sumayah Abid Al-Mahmood 🇮🇶 is a passionate pharmaceutical scientist specializing in nanotechnology, drug formulation, and drug delivery systems 💊🧪. Currently a PhD candidate at the University of Baghdad 🏛️, she also holds a Master’s in Pharmaceutical Sciences from Rutgers University, USA 🇺🇸 and a Bachelor’s degree from Tikrit University 🎓. With over 17 publications, 431 citations, and an emerging H-index of 3, her research contributions span innovative topical, oral, and transdermal delivery technologies. Dr. Sumayah has served as an instructor and lab supervisor 🧑‍🏫, clinical pharmacist 💉, and student coordinator 🎯. Her work addresses both local and global pharmaceutical challenges, including COVID-19, oral cancer, and antifungal therapies. She is also an active member of AAPS and the Iraqi Pharmacy Syndicate 🌍. Her commitment to education, research, and healthcare makes her a strong candidate for the Best Researcher Award 🏅.

Professional Profile:

Google Scholar

🏅Suitability For Best Researcher Award – Mrs. Sumayah Al-Mahmood

Dr. Sumayah Abid Al-Mahmood brings a compelling combination of academic rigor, international training, and impactful research in pharmaceutics. Her specialization in nanotechnology-based drug delivery systems addresses both foundational science and real-world healthcare needs, such as COVID-19, cancer therapy, and antifungal treatments. With over 17 publications, 431 citations, and a rising H-index, she demonstrates a growing influence in her field. Additionally, her cross-continental education—from Rutgers University, USA to the University of Baghdad—underscores her global outlook and adaptability. Her long-standing commitment to teaching, mentorship, and clinical practice further strengthens her profile as a well-rounded and impactful researcher.

🎓 Education

Dr. Sumayah Abid Al-Mahmood’s academic journey reflects a blend of local dedication and international excellence 🌍. She is currently pursuing her PhD in Pharmaceutics at the University of Baghdad, Iraq 🏛️. She earned her Master of Pharmaceutical Sciences from Rutgers University, USA in 2016 🎓🇺🇸, gaining advanced expertise in drug delivery technologies and research methodologies. Her foundational degree, Bachelor of Pharmacy, was awarded by Tikrit University, Iraq in 2007 💊🇮🇶. Through these institutions, she developed deep knowledge in molecular pharmaceutics, dermaceutics, and engineered drug systems 🧬🧪, shaping her into a capable and forward-thinking researcher.

🧑‍🏫 Experience

Dr. Sumayah brings over 15 years of diverse professional experience in academia, healthcare, and pharmaceutical science 🔬. She currently serves as an Instructor at University of Al-Iraqia (2018–present) 🏫, teaching courses like pharmacology and medical terminology. Earlier, she worked as a Laboratory Supervisor at Tikrit University (2008–2013) 🔍, where she instructed biopharmaceutics and pharmaceutical chemistry. From 2008–2009, she practiced as a Clinical Pharmacist at Tikrit Hospital 🏥, delivering care across departments including pediatrics and surgery. Additionally, she plays a key role in student coordination at the College of Dentistry 🎓, reflecting her leadership and mentorship abilities.

📚 Professional Development

Dr. Sumayah is committed to continuous growth through professional training and academic engagement 📈. She participated in multiple teaching assistant workshops at Rutgers University, including courses in poster design, Excel grading, and digital communication 💻📝. She holds a CPR AED certificate from the American Heart Association and the Internet and Computer Core Certification (IC3) from 2010 💾🛡️. A student member of the American Association of Pharmaceutical Scientists (AAPS) from 2013–2016 and a long-time member of the Iraqi Pharmacy Syndicate 🧑‍🔬🇮🇶, she actively contributes to professional communities. Her fluency in Arabic 🗣️ and technical proficiency with MS Office tools help her in both research and instruction. These credentials demonstrate her dedication to evolving with scientific advances and pedagogical innovations 🌐📖.

🔬 Research Focus Area

Dr. Sumayah’s research is focused on pharmaceutics, particularly in the development of innovative drug delivery systems 💊. Her work explores nanotechnology-based carriers such as ufasomes, solusomes, and buccal films, targeting enhanced bioavailability and controlled release 🧬🔄. She has published extensively on transdermal, nasal, and oral delivery techniques, with therapeutic applications ranging from antifungal agents to CNS-targeting drugs 🧠⚕️. Her research also addresses public health concerns, including COVID-19 vaccine acceptance, oral cancer treatment, and antibiotic resistance 🦠💉. By combining laboratory techniques with clinical relevance, she contributes to both pharmaceutical innovation and public health betterment. Her publications across journals like OpenNano, Current Drug Delivery, and Drug Delivery & Translational Research reflect the translational value of her work. Thus, her research fits squarely in the “Drug Delivery and Pharmaceutical Nanotechnology” category 🧪🏅.

🧠 Research Skills Category

Dr. Sumayah demonstrates expertise across a range of advanced pharmaceutical research skills 🧪. These include formulation development, nanoparticle preparation, mucoadhesive systems, and thermosensitive gel design ⚗️🧬. She is adept in in vitro, ex vivo, and optimization studies, often using response surface methodology for formulation tuning 📊🧠. Her analytical skills extend to statistical research design, literature review, and writing for publication, supported by coursework in molecular pharmaceutics and membrane transport 🧾📚. She also explores phytochemistry, antimicrobial resistance, and oral health science, revealing her interdisciplinary capabilities. Her digital competencies, such as Microsoft tools and scientific software, further enhance her lab and teaching productivity 💻📈. As such, her skills align with the “Formulation Science, Drug Delivery Engineering, and Translational Pharmaceutics” category, bridging bench science and clinical application effectively 🧫💊.

🏅 Awards and Honors

While Dr. Sumayah has not listed formal awards, her achievements reflect high academic and research merit 🏆. Publishing 17 peer-reviewed articles, contributing to global conferences, and earning over 430 citations 📑🌐 positions her as a recognized scholar in pharmaceutics. Her publications in high-visibility journals and consistent research output indicate a growing influence in nanotechnology-driven drug delivery. She earned her Master’s degree from Rutgers University, a prestigious U.S. institution 🇺🇸🎓, reflecting international academic distinction. As a nominee for the Best Researcher Award, her multidisciplinary impact, publication record, and dedication to pharmaceutical sciences demonstrate excellence worthy of formal recognition 🥇📘.

Publication Top Notes

📘 1. Metastatic and Triple-Negative Breast Cancer: Challenges and Treatment Options

Authors: S. Al-Mahmood, J. Sapiezynski, O.B. Garbuzenko, T. Minko
Journal: Drug Delivery and Translational Research, 2018, Vol. 8, pp. 1483–1507
Citations: 611
Summary:
This highly cited review discusses the complexities of treating metastatic and triple-negative breast cancer (TNBC), a subtype with poor prognosis. It evaluates emerging nanotechnology-based drug delivery systems, molecular targets, and personalized therapies aimed at improving outcomes for TNBC patients.

📘 2. Acceptance of COVID-19 Vaccine Among General Population in Iraq

Authors: H. Faisal Ghazi, T. Taher Mohammed Jwad, S. Abdul Lateef Alfadhul, S. Al-Mahmood, et al.
Journal: Iraqi National Journal of Medicine, 2021, Vol. 3(1)
Citations: 21
Summary:
This study explores public perception, barriers, and willingness to receive the COVID-19 vaccine among Iraq’s general population. It provides data on factors influencing vaccine acceptance, helping to guide public health strategies and communication during pandemics.

📘 3. Comparative Evaluation of the Effectiveness of 40% Miswak Mouthwash and 0.12% Chlorhexidine Mouthwash in Treating Gingivitis: A Blinded, Randomised Clinical Trial

Authors: S. Al-Mahmood, D. Wadeea Sabea
Journal: Oral Health & Preventive Dentistry, 2021, Vol. 19(1), pp. 229–233
Citations: 9
Summary:
This randomized clinical trial compares the efficacy of a natural Miswak-based mouthwash with a standard chlorhexidine rinse in gingivitis treatment. Results indicate that Miswak may serve as a cost-effective and culturally acceptable alternative with fewer side effects.

📘 4. Microbiological Profile with Antibiotic Resistance Pattern in Patients of Pneumonia in Iraq

Authors: A.I. Jaaffar, S. Al-Mahmood, R.K. Maeh, M. Alyasiry
Journal: Drug Invention Today, 2019, Vol. 11(11), pp. 2913–2916
Citations: 7
Summary:
This paper provides microbiological analysis and resistance profiles of pathogens isolated from pneumonia patients in Iraq. It highlights the growing issue of antibiotic resistance, aiding clinicians in selecting more effective empirical therapies.

📘 5. Estimation of the Antibacterial Effect of Curcumin and Rosemary Among Patients with Dental Caries In Vitro

Authors: E. Al-Sharifi, A. Al-Mahmood, S. Al-Mahmood
Journal: Asian Journal of Pharmaceutical and Clinical Research, 2019, Vol. 12(3), pp. 277–279
Citations: 4
Summary:
This in vitro study evaluates the antibacterial efficacy of curcumin and rosemary extracts against bacteria causing dental caries. The findings support the potential of these natural agents as adjuncts in oral healthcare products.

✅ Conclusion

Dr. Sumayah Abid Al-Mahmood exemplifies the values of the Best Researcher Award through her scientific innovation, academic dedication, international credentials, and contributions to global health challenges. Her work not only pushes the boundaries of pharmaceutical research but also directly translates into societal benefit. With her strong publication record, cross-sectoral experience, and future research potential, she is highly deserving of this award recognition. 🏆💊🌍